InsiderTrades

Form 4 for MIRM Mirum Pharmaceuticals, Inc.

Accepted 2024-06-25 00:00:00 ET · period of report 2024-06-24 · accession 0001415889-24-018159 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-06-25 2024-06-24 MIRM Vig Pamela CSO S - Sale+OE $34.00 -30.6K 27.4K -53% -$1.04M
D 2024-06-25 2024-06-24 MIRM Vig Pamela CSO M - OptEx $2.94 +30.6K 58.0K +112% +$89.8K
D 2024-06-25 2024-06-24 MIRM Vig Pamela CSO M - OptEx $0.00 -30.6K 125.7K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-24 S D 30,559 $34.00 27,406 D — —
2 Common Common Stock 2024-06-24 M A 30,559 $2.94 57,965 D — —
3 Derivative Stock Option (right to buy) 2024-06-24 M D 30,559 $0.00 125,691 D $2.94 · — to 2029-03-11 30,559 Common Stock (F2) The stock option is fully vested.